The calcium channel blocker nifedipine fails to inhibit leucocyte elastase release during cardiopulmonary bypass

Acta Anaesthesiol Scand. 1993 Jan;37(1):82-4. doi: 10.1111/j.1399-6576.1993.tb03604.x.

Abstract

Circulating concentrations of leucocyte elastase were measured in 16 adult patients undergoing cardiopulmonary bypass (CPB) with a flat-sheet membrane oxygenator. Eight patients (Group I) received the calcium channel blocker nifedipine (9 micrograms.kg-1 x h-1) during CPB. Eight patients (Group II) did not receive any calcium channel blocker during surgery and served as the control group. Elastase concentrations were measured at 7 time points: 2 before, 2 during, and 3 after CPB. The bypass procedure was associated with elevation in elastase concentrations (P < 0.001). Comparing to baseline values elastase concentrations were significantly elevated (P < 0.05) 60 min after the start of CPB and on all measurements done after CPB. Elastase concentrations correlated with the duration of CPB (rs = 0.76, P < 0.001), and were not influenced by nifedipine infusion as revealed by comparing the two groups. This study demonstrates moderate elastase release during CPB with a flat-sheet membrane oxygenator and fails to confirm inhibition of elastase release by nifedipine infusion during CPB.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Cardiopulmonary Bypass*
  • Female
  • Humans
  • Leukocytes / enzymology*
  • Male
  • Middle Aged
  • Nifedipine / pharmacology*
  • Pancreatic Elastase / blood*

Substances

  • Pancreatic Elastase
  • Nifedipine